CRTC1 and neoplasm: M2-like macrophage activation, immunosuppressive tumor microenvironment, and tumor growth were reversed by inhibiting LAMP2A, whose targets were found to be peroxiredoxin 1 (PRDX1) and CREB-regulated transcription coactivator 1 (CRTC1) [260].